Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Deals get done

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Aug 23, 2021 5:20pm

99 Views

Post# 33750809

RE:RE:RE:RE:RE:Deals get done

I get more of a sense of thtx tracking the general/biotech indices a little more than it used to. If you put up a comparison chart of the last 3 months it almost perfectly matches the ups and downs of the XBI. I'm tempted to think this is a sign there are more eyes on the stock.

SPCEO1 wrote: Not unless there is serious volume and/or news that is driving the price action.

qwerty22 wrote:
Interesting day. Does the after hours action matter?

muslix1 wrote:
good volume in US ...
there is something brewing...